CV6 Therapeutics, (NI) Ltd.
Kylie McLaughlin is an Associate Principal Scientist at CV6 Therapeutics, (NI) Ltd., with a background in research, teaching, and visiting scholar roles at Queen's University Belfast and Karolinska Institutet. Kylie completed their Doctor of Philosophy in Medicine (Oncology) and has experience in molecular biology techniques, laboratory demonstration, and teaching assistance in medical programs. Kylie has also researched drug resistance and chemotherapy combination treatments in colorectal cancer models.
This person is not in any teams
CV6 Therapeutics, (NI) Ltd.
CV6 Therapeutics is developing value-based, first-in-class medications that are scalable to address global unmet medical needs in the oncology and inflammatory disease markets. For further questions or information on investment or career opportunities please contact: information@cv6t.com